ATX 4.92% 6.4¢ amplia therapeutics limited

Thoughts on ATX, is it a multi bagger?, page-3

  1. 300 Posts.
    lightbulb Created with Sketch. 72
    small biotech is always a risky game, but at least FAK inhibitors have already been shown elsewhere to be efficacious in clinical trials:

    FAK-targeted and combination therapies for the treatment of cancer: an overview of phase I and II clinical trials
    https://www.tandfonline.com/doi/abs/10.1080/13543784.2020.1740680?journalCode=ieid20

    "The FAK inhibitors examined in clinical trials thus far have been shown to have manageable toxicity profiles and have demonstrated cytostatic effects as single agents, extending progression-free survival without producing a clinical or radiographic response. Trials are currently underway to strengthen the efficacy of treatment by combining FAK inhibitors with cytotoxic chemotherapy, targeted therapy, or immunotherapy. "

    and with the current atx market cap, seems almost nothing is priced in here
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.4¢
Change
0.003(4.92%)
Mkt cap ! $17.38M
Open High Low Value Volume
6.1¢ 6.6¢ 6.1¢ $28.65K 462.7K

Buyers (Bids)

No. Vol. Price($)
2 50642 5.8¢
 

Sellers (Offers)

Price($) Vol. No.
6.6¢ 131151 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.